𝔖 Bobbio Scriptorium

✦ LIBER ✦

A phase III randomized trial comparing neoadjuvant chemotherapy and upfront debulking surgery is indispensable as a basis for changing the standard treatment of advanced Müllerian cancer

✍ Scribed by Takashi Onda; Hiroyuki Yoshikawa

Book ID: 113962038
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 65 KB
Volume: 114
Category: Article
ISSN: 0090-8258
DOI: 10.1016/j.ygyno.2009.04.011

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

4BA A randomized phase III study compari

4BA A randomized phase III study comparing epirubicin, docetaxel, and capecitabine (EDC) to epirubicin and docetaxel (ED) as neoadjuvant treatment for early breast cancer – first results of the Austrian Breast and Colorectal Cancer Study Group-Trial 24 (ABCSG-24)

✍ G.G. Steger; R. Greil; R. Jakesz; A. Lang; B. Mlineritsch; E. Melbinger-Zeinitze 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 49 KB

Paclitaxel plus cisplatin is as effectiv

Paclitaxel plus cisplatin is as effective as regimens containing gemcitabine in people with advanced non-small cell lung cancer: Abstracted from: Smit EF, van Meerbeeck JP, Lianes P, et al. Three-arm randomized study of two cisplatin-based regimens and paclitaxel plus gemcitabine in advanced non-small-cell lung cancer: a phase III trial of the European Organization for Research and Treatment of Cancer Lung Cancer Group-EORTC 08975. J Clin Oncol 2003;21:3909–17.

✍ Sarah Danson 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 163 KB